Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127076351 | 12707635 | 1 | I | 20090615 | 20090701 | 20160901 | 20160901 | EXP | US-PFIZER INC-2009234532 | PFIZER | 67.00 | YR | M | Y | 118.00000 | KG | 20160901 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127076351 | 12707635 | 1 | PS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK | 18989 | TABLET | |||||||||
| 127076351 | 12707635 | 2 | SS | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | Oral | 60 MG, EVERY 12 HOURS | 19999 | 60 | MG | ||||||||
| 127076351 | 12707635 | 3 | SS | HYDROCODONE W/ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 10/325 MG | U | 0 | |||||||||
| 127076351 | 12707635 | 4 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | Oral | 20 MG, 1X/DAY | 800 | MG | 5078102 | 0 | 20 | MG | CAPSULE | QD | |||
| 127076351 | 12707635 | 5 | C | DARVOCET-N 100 | ACETAMINOPHENPROPOXYPHENE NAPSYLATE | 1 | Oral | 100 UNK, 4X/DAY | 0 | QID | |||||||||
| 127076351 | 12707635 | 6 | C | FIORICET | ACETAMINOPHENBUTALBITALCAFFEINE | 1 | Oral | UNK | 0 | ||||||||||
| 127076351 | 12707635 | 7 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | QD | |||||||
| 127076351 | 12707635 | 8 | C | METHOCARBAMOL. | METHOCARBAMOL | 1 | Oral | 750 MG, 4X/DAY | 0 | 750 | MG | QID | |||||||
| 127076351 | 12707635 | 9 | C | NEURONTIN | GABAPENTIN | 1 | Oral | 600 MG, 3X/DAY | 0 | 600 | MG | TID | |||||||
| 127076351 | 12707635 | 10 | C | PHENOBARBITAL. | PHENOBARBITAL | 1 | Oral | 30 MG, 1X/DAY | 0 | 30 | MG | QD | |||||||
| 127076351 | 12707635 | 11 | C | RIFAMPIN. | RIFAMPIN | 1 | Oral | 300 MG, 2X/DAY | 0 | 300 | MG | BID | |||||||
| 127076351 | 12707635 | 12 | C | TEMAZEPAM. | TEMAZEPAM | 1 | Oral | 15 MG, 1X/DAY | 0 | 15 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127076351 | 12707635 | 1 | Osteoarthritis |
| 127076351 | 12707635 | 4 | Prophylaxis against gastrointestinal ulcer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127076351 | 12707635 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127076351 | 12707635 | Hypovolaemia | |
| 127076351 | 12707635 | Mental status changes | |
| 127076351 | 12707635 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127076351 | 12707635 | 1 | 20090423 | 20090531 | 0 | |
| 127076351 | 12707635 | 3 | 20090213 | 0 | ||
| 127076351 | 12707635 | 4 | 20090422 | 20090531 | 0 | |
| 127076351 | 12707635 | 7 | 20070201 | 0 | ||
| 127076351 | 12707635 | 8 | 20080819 | 0 | ||
| 127076351 | 12707635 | 9 | 20090213 | 0 | ||
| 127076351 | 12707635 | 10 | 20090109 | 0 |